Imagen de Portada
Código QR

Real-world observational data factor into FDA's decisions.

Publicado en:American Journal of Health-System Pharmacy Vol. 75; no. 6; pp. 338 - 340
Autor principal: Thompson, Cheryl A.
Formato: Journal Article
Publicado: Oxford University Press / USA 3/15/2018
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=128520426&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 128520426
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10792082
        1X3
      jtl: American Journal of Health-System Pharmacy
      issn: 10792082
      maglogo: N
    pubinfo:
      dt: 3/15/2018
      vid: 75
      iid: 6
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        128520426
        10.2146/news180019
        128520426
      ppf: 338
      ppct: 2
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Real-world observational data factor into FDA's decisions.
      aug:
        au: Thompson, Cheryl A.
      sug:
        subj:
          United States Food and Drug Administration
          Decision Making, Clinical
          Drug Monitoring
          Drug Labeling
          Contrast Media Adverse Effects
          Perinatal Death Risk Factors
          Meetings
          Ketoconazole Administration and Dosage
          Mycoses Drug Therapy
          Electronic Health Records
          Medicare
          Ketoconazole Adverse Effects
          Liver Injuries
          Administration, Oral
          Pregnancy
          Female
          Female
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N